2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

Affiliations

• ¹ Special Advisor to the board, and Past president (ex officio), World Hypertension League, Hong Kong, China. ncampbel@ucalgary.ca.
• ² Department of Medicine, University of Calgary, Calgary, AB, Canada. ncampbel@ucalgary.ca.
• ³ President-Elect, World Hypertension League, Hong Kong, China.
• ⁴ Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
• ⁵ Vice President, World Hypertension League, Hong Kong, China.
• ⁶ Yale University, New Haven, CT, USA.
• ⁷ Sanatorio Allende, Córdoba, Argentina.
• ⁸ Chair, International Society of Hypertension, Membership Committee, International Society of Hypertension, Colchester, UK.
• ⁹ Department of Pharmacology and Experimental Therapeutics and the Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA.
• ¹⁰ Past President, British and Irish Hypertension Society, Edinburgh, UK.
• ¹¹ University of Warwick, WHO Collaborating Centre for Nutrition, Warwick Medical School, Coventry, UK.
• ¹² Resolve to Save Lives, an Initiative of Vital Strategies, New York, NY, USA.
• ¹³ WHO Collaborating Centre on Population Salt Reduction, Sydney, NSW, Australia.
• ¹⁴ The George Institute for Global Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, Paddington, London, UK.
• ¹⁵ The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
• ¹⁶ Wolfson Institute of Population Health, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.
• ¹⁷ Department of Preventive & Social Medicine, University of Otago, Dunedin, New Zealand.
• ¹⁸ Costa Rican Institute of Research and Teaching in Nutrition and Health (INCIENSA), Tres Rios, Costa Rica.
• ¹⁹ Officer at Large, International Society of Hypertension, Chair International Society of Hypertension Research and Education Committee, International Society of Hypertension, Colchester, UK.
• ²⁰ Center for Health Evaluation and Outcomes Sciences, University of British Columbia, Vancouver, BC, Canada.
• ²¹ International Society of Hypertension Education Lead, Colchester, UK.
• ²² Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
• ²³ Advisor Food, Nutrition and Physical Activity in Schools, Pan American Health Organization, Washington DC, MD, USA.
• ²⁴ Faculty of Health Sciences, Ontario Tech University, Oshawa, ON, Canada.
• ²⁵ Chair, Action on Salt, London, UK.
• ²⁶ Chair, Action on Sugar, London, UK.
• ²⁷ Chair, World Action on Salt Sugar and Health (WASSH), London, UK.
• ²⁸ Chair Blood Pressure UK, London, UK.
• ²⁹ Board member, Director (Sub-Saharan Africa), World Hypertension League, Hong Kong, China.
• ³⁰ Dean, Faculty of Clinical Sciences, Director Center for Genomic and Precision Medicine, College of Medicine,  University of Ibadan, Ibadan, Nigeria.
• ³¹ World Stroke Organization Geneva, Geneva, Switzerland.
• ³² Lead Co-Chair Lancet Commission on Stroke, London, UK.
• ³³ Past President (ex officio), World Hypertension League, Hong Kong, China.
• ³⁴ Secretary-General, World Hypertension League, Hong Kong, China.
• ³⁵ Italian Society of Arterial Hypertension, Milan, Italy.
• ³⁶ Department of Medicine and Surgery, University of Milano-Bicocca and IRCCS, Istituto Auxologico Italiano, Milan, Italy.
• ³⁷ Past President, World Hypertension League, Hong Kong, China.
• ³⁸ Division of Translational Neurosciences and Population Studies, Department of Neurology, Medical University of South Carolina, Charleston, SC, USA.
• ³⁹ Treasurer, International Society of Hypertension, Colchester, UK.
• ⁴⁰ Health Innovation and Transformation Centre, Federation University Australia, Ballarat, VIC, Australia.
• ⁴¹ Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
• ⁴² Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC, Australia.
• ⁴³ Secretary, International Society of Hypertension, Colchester, UK.
• ⁴⁴ University College London, NIHR University College London, Hospitals Biomedical Research Centre, London, UK.
• ⁴⁵ President, International Society of Hypertension, Colchester, UK.
• ⁴⁶ Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.
• ⁴⁷ Manchester Heart Centre and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
• ⁴⁸ Chair, International Society of Hypertension Regional Advisory Group - Americas Colchester, Colchester, UK.
• ⁴⁹ Department of Internal Medicine, Emory University, Atlanta, Georgia.
• ⁵⁰ Director, Coalición Latinoamérica Saludable (CLAS), McKinney, TX, USA.
• ⁵¹ Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
• ⁵² Director, WHO Collaborating Centre on Nutrition Policy for Chronic Disease Prevention, Toronto, ON, Canada.
• ⁵³ Advisor, Executive Committee, World Hypertension League, Hong Kong, China.
• ⁵⁴ Professor of Medicine, Division of Cardiovascular Disease, State University of New York, Downstate Medical Center, New York, NY, USA.
• ⁵⁵ President, High Blood Pressure Research Council of Australia, Tuggerah, NSW, Australia.
• ⁵⁶ Dobney Hypertension Centre, Medical School - Royal Perth Hospital Unit, Royal Perth Hospital Research Foundation, The University of Western Australia, Perth, WA, Australia.
• ⁵⁷ President, International Society of Nephrology, Brussels, Belgium.
• ⁵⁸ Professor of Pathology, Microbiology and Immunology, Professor of Medicine, John L. Shapiro Chair of Pathology, Professor of Pediatrics, Vanderbilt University, Nashville, TN, USA.
• ⁵⁹ Co-Chair Global Policy Committee, member of the Executive Committee, World Stroke Organization, Geneva, Switzerland.
• ⁶⁰ Director of National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand.
• ⁶¹ Founding Chair, Steering Committee, African Stroke Organization, Ibadan, Nigeria.
• ⁶² Institute for Advanced Medical Research and Training and Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
• ⁶³ Past President, Argentine Society of Arterial Hypertension, Buenos Aires, Argentina.
• ⁶⁴ Advisor to the Academic Vice-Chancellor, Maimonides University, Buenos Aires, Argentina.
• ⁶⁵ Founder and Secretary, Dr Bindu Menon Foundation (India), Nellore, India.
• ⁶⁶ Nutritionist, Brazilian Society of Hypertension, Sao Paulo, Brazil.
• ⁶⁷ Past President, Brazilian Society of Hypertension, Sao Paulo, Brazil.
• ⁶⁸ Full Professor of Internal Medicine and Director of the Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
• ⁶⁹ Board member, Director - Eastern European Regional Office, World Hypertension League, Hong Kong, China.
• ⁷⁰ Member, Research and Education Committee, International Society of Hypertension, Colchester, UK.
• ⁷¹ Bulgarian League of Hypertension, President of Bulgarian Society of Cardiovascular Imaging, Sofia, Bulgaria.
• ⁷² Sofia University, Faculty of Medicine, Center of Cardiovascular diseases, Sofia, Bulgaria.
• ⁷³ Chief Executive Officer, Canadian Cardiovascular Society, Ottawa, ON, Canada.
• ⁷⁴ President, Canadian Society of Nephrology, Montreal, QC, Canada.
• ⁷⁵ President, Cardiology Branch, Chinese Medical Doctors Association, Beijing, China.
• ⁷⁶ President, Chilean Society of Hypertension, Santiago, Chile.
• ⁷⁷ Advanced Center for Chronic Diseases (ACCDiS), Division de Enfermedades Cardiovasculares, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
• ⁷⁸ President, Chinese Hypertension League, Beijing, China.
• ⁷⁹ The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• ⁸⁰ President, Czech Society of Hypertension, Prague, Czech Republic.
• ⁸¹ President, European Society of Hypertension, Zug, Switzerland.
• ⁸² Charité - Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
• ⁸³ Chairman of the Board, German Society of Hypertension, Heidelberg, Germany.
• ⁸⁴ Past President, Treasurer, High Blood Pressure Research Council of Australia, Tuggerah, NSW, Australia.
• ⁸⁵ Director, Policy and Advocacy, Heart and Stroke Foundation of Canada, Ottawa, ON, Canada.
• ⁸⁶ Board member, Hellenic Society of Hypertension, Athens, Greece.
• ⁸⁷ National and Kapodistrian University of Athens, Athens, Greece.
• ⁸⁸ Treasurer, Hellenic Society of Hypertension, Athens, Greece.
• ⁸⁹ Aristotle University of Thessaloniki, Thessaloniki, Greece.
• ⁹⁰ Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
• ⁹¹ School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
• ⁹² Chief Program Officer, Hypertension and Nutrition Core Group of India Association for Parenteral and Enteral Nutrition (IAPEN), Maharashtra, India.
• ⁹³ Director of IAPEN, Maharashtra, India.
• ⁹⁴ President, Hong Kong College of Cardiology, Hong Kong, China.
• ⁹⁵ Secretary General, Hungarian Society of Hypertension, Budapest, Hungary.
• ⁹⁶ Department of Family Medicine, Semmelweis University, Budapest, Hungary.
• ⁹⁷ President, Hypertension Canada, Toronto, ON, Canada.
• ⁹⁸ President, Indian Society of Hypertension, Lucknow, India.
• ⁹⁹ Board Member, World Hypertension League, Hong Kong, China.
• ¹⁰⁰ President Elect, Iranian Heart Federation, Tehran, Iran.
• ¹⁰¹ Professor of Medicine and Cardiology, Director of Isfahan Cardiovascular Research Center, Isfahan, Iran.
• ¹⁰² WHO Collaborating Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
• ¹⁰³ Executive Director, InterAmerican Heart Foundation (IAHF), Dallas, TX, USA.
• ¹⁰⁴ International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), Markham, ON, Canada.
• ¹⁰⁵ Singapore Heart Foundation, Singapore, Singapore.
• ¹⁰⁶ President, Japanese Society of Hypertension, Tokyo, Japan.
• ¹⁰⁷ President, Latin American Society of Hypertension, Buenos Aires, Argentina.
• ¹⁰⁸ Arterial Hypertension and Metabolic Unit, University Hospital, Fundacion Favaloro, Medical Sciences Faculty, University Dr. RG Favaloro, Buenos Aires, Argentina.
• ¹⁰⁹ President, Latin American Society of Nephrology and Hypertension, Innova, Panama.
• ¹¹⁰ Past President of the Central American and Caribbean Association of Nephrology and Hypertension, Santa Domingo, Dominican Republic.
• ¹¹¹ President, Lebanese Hypertension League, Beirut, Lebanon.
• ¹¹² President, Korean Society of Community Nutrition, Seoul, South Korea.
• ¹¹³ Seoul National University Seoul, Seoul, South Korea.
• ¹¹⁴ President, Korean Society of Hypertension, Seoul, South Korea.
• ¹¹⁵ Division of Cardiology, The Catholic University of Korea, Seoul, South Korea.
• ¹¹⁶ Immediate Past President, Malaysian Society of Hypertension, Selangor, Malaysia.
• ¹¹⁷ President, Malaysian Society for World Action on Salt, Sugar and Health (MyWASSH), Selangor, Malaysia.
• ¹¹⁸ Department of Medical Sciences, School of Medical and Live Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia.
• ¹¹⁹ President, Mongolian Society of Hypertension, Ulaanbaatar, Mongolia.
• ¹²⁰ Department of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
• ¹²¹ General Director, National Institute of Food and Nutrition Service, Seoul, South Korea.
• ¹²² Secretary-General, Nigerian Hypertension Society, Ibadan, Nigeria.
• ¹²³ Department of Medicine, University of Ilorin, Ilorin, Nigeria.
• ¹²⁴ NCD Global Program Leader, PATH, Seattle, WA, USA.
• ¹²⁵ Chief Executive Officer and Co-Founder Onom Foundation, Onom Foundation, Ulaanbaatar, Mongolia.
• ¹²⁶ Secretary General and Founder Trustee, Pakistan Hypertension League, Karachi, Pakistan.
• ¹²⁷ Chair of International Society of Hypertension Regional Advisory Group South, and Central Asia, Colchester, UK.
• ¹²⁸ Karachi Institute of Heart Diseases, Karachi, Pakistan.
• ¹²⁹ President, Philippine Society of Hypertension, Pasig City, Philippines.
• ¹³⁰ Department of Medicine, University of the Philippines College of Medicine and St. Luke's Medical Center, Quezon City, Philippines.
• ¹³¹ Immediate Past President, Philippine Society of Hypertension, Pasig City, Philippines.
• ¹³² Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
• ¹³³ President, Polish Society of Hypertension, Gdansk, Poland.
• ¹³⁴ Department of Hypertension, National Institute of Cardiology, Warsaw, Poland.
• ¹³⁵ Co-Director, Primary Aldosteronism Foundation, Phoenix, AZ, USA.
• ¹³⁶ Coordinator, Portuguese Society of Paediatric Working Group on Blood Pressure in Children and Adolescents, Lisbon, Portugal.
• ¹³⁷ President, Portuguese Society of Hypertension, Lisbon, Portugal.
• ¹³⁸ Head, Continuous Professional Development, Saudi Hypertension Management Society, Riyadh, Saudi Arabia.
• ¹³⁹ President, Swedish Society for Hypertension, Stroke and Vascular Medicine, Stockholm, Sweden.
• ¹⁴⁰ Associate Professor in Cardiology, Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.
• ¹⁴¹ Chairman, Slovak League against Hypertension, Bratislava, Slovakia.
• ¹⁴² Past President, Serbian Society of Hypertension, Nis, Serbia.
• ¹⁴³ Clinic for Internal disease Intermedica Cardiology Department, Hypertensive Centre, Singidunum University, School of Medicine, Belgrade, Serbia.
• ¹⁴⁴ President, World Hypertension League, Hong Kong, China.